Posters
CKD: Omics, Systemic Stressors, and Targeted Pharmacotherapy
October 23, 2026 | 10:00 AM - 12:00 PM
Location: Exhibit Hall A, Convention Center
Session Description
Poster Session
Posters
Allostatic Load with CKD and Mortality in US Adults
Incidence of Herpes Zoster Among US Patients with CKD
Superficial Fungal Infection and Clinical Outcomes in Patients with CKD
Plant-Based Diet Adherence and Mitochondrial DNA Copy Number in Individuals with CKD
Contemporary Use of RAS Inhibitors and SGLT2 Inhibitors in US Adults with Advanced CKD
Urine Symmetric Dimethylarginine and Methylmalonic Acid Identify Sickle Cell Disease-Associated CKD Across Three Definitions and Associate with Continuous Glomerular Filtration Rate
High-Dimensional Generative Latent Representations Capture the Pathophysiological Structure of CKD and Improve Survival Prediction
Declining Rates of RAS Inhibitor Use Coinciding with Availability of Newer Therapies for Patients with CKD
APOL1-Mediated Kidney Disease (AMKD) Progression Among People Living with HIV
Effect of an Embedded Pharmacist on SGLT2 Inhibitor Use in a CKD Clinic
Selection Bias Precludes Clinical Use of Kidney Function Polygenic Scores in CKD Populations
Adiponectin, Leptin, APOL1 Genotypes, and Kidney Outcomes in the REGARDS Cohort
Metabolomic Biomarkers for Predicting Kidney Prognosis in Hypertension-Associated CKD and Evaluation of Their Toxicity in a Kidney Failure Model
Microvascular Health Score and Data-Driven Microvascular Phenotypes in CKD: Findings from the MAP-CKD Study
Association of Kidney Contrast-Enhanced, Ultrasound-Derived Microvascular Perfusion with Kidney Function and Histopathology
Phenotypic Clustering Reveals Distinct CKD Metabolic and Complication Profiles
Lipid Profile and Risk of Hospitalization with Infection in Patients with CKD: The CRIC Study
Quality of Life (QOL), Kidney, and Survival Outcomes in Patients with CKD: CKD Japan Cohort (CKD-JAC) 2 Study
Proteinuria Modifies the Association Between Serum Uric Acid and Subsequent Decline in eGFR: Community-Based Cohort
Biomarkers of Tubular Injury and Immune Activation Across APOL1 Genotypes
The Power of Human-Centered Multidisciplinary Care in CKD: Real-World Outcomes from a Single-Center Cohort
Effects of Normal-Protein vs. Low-Protein Diet on Renal Functional Reserve in CKD Stages 3 and 4: A Randomised Controlled Trial
Plasma Proteomic Biomarkers Associated with Prevalent and Incident CKD in a Population-Based Cohort
Sex Hormone Levels and eGFR Assessed by Creatinine and Cystatin C in the Framingham Cohort Study
Functional Capacity Is Impaired in Patients with Nondialysis-Dependent CKD and Obstructive Lung Disease
Albuminuria, but Not Reduced eGFR, Is Associated with Hearing Loss in Adults: A KDIGO Heatmap Analysis from KNHANES
Increased Risk of Acute Respiratory Illness and Benefits of COVID-19 Vaccination Among Guatemalan Agricultural Workers with CKD
Nurse-Led, Person-Centred Quality Improvement Increases Pneumococcal Vaccination Coverage in Patients with Advanced CKD: Experience from a Multicultural Low-Clearance Clinic in Qatar
Bile Acid Sequestrants and Kidney Outcomes in Patients with CKD
Quality of Life and Treatment Preferences for Conservative Kidney Management or Kidney Replacement: Baseline Data from a Prospective Multicenter Cohort Study of Patients with ESKD in Japan
Association Between Untreated Dental Caries and Proteinuria in Patients with CKD
Exceptional Parental Longevity and Kidney Function Decline in Older Adults
Choosing Wisely for Patients with Kidney Diseases: Nonsteroidal Anti-Inflammatory Drug Prescriptions in an Acute Care Hospital
Higher Serum Angiopoietin-Like Protein 2 Is Associated with Subsequent eGFR Decline but Not Albuminuria
Intrinsic Capacity as a Measure of Successful Aging and Its Association with Mortality in Adults with CKD
Low Physical Function Associated with Higher Risk of Incident Cognitive Impairment in Adults with CKD
Acculturation and Risk of Death in US Hispanic Adults with CKD
Objective vs. Self-Reported Physical Function and Mortality in CKD
Sickle Cell Nephropathy Mortality in the United States, 1999-2024: Persistent Racial Inequity in the Disease-Modifying Therapy Era
Frontal Cerebral Blood Flow Decline Is Selectively Associated with Worsening Executive Function in CKD: Post Hoc Analyses of the SPRINT-MIND Study
From Heat to Cold: A Case of Mesoamerican Nephropathy
Association of Guideline-Directed Medical Therapy and Hospitalization Risk in Patients with CKD
Assessing CKD of Unknown Etiology (CKDu) Using a Computable Phenotype at a Quaternary Academic Medical Center in Florida
Baseline Assessment of SGLT2 Inhibitor Underuse in Outpatient CKD Clinics: A Quality Improvement Initiative
Uric Acid Testing in US Veterans with CKD: Associations with Kidney Function, Gout, and Patient Characteristics
Morphometry of Dysmorphic Lysosomal Inclusion Bodies by Transmission Electron Microscopy
Prevalence and Occupational Determinants of CKD of Uncertain Etiology in Mesoamerica: A Systematic Review and Meta-Analysis
Temporal Trends and Characteristics of SGLT2 Inhibitor Use in Veterans with Sickle Cell Disease
Stage-Specific Gout Prevalence and Correlates Among US Veterans with CKD
Association of Serum Uric Acid with Early Albuminuria in Adults Without Diabetes or CKD: An NHANES Analysis
Guideline-Directed Medical Therapy in Patients with CKD: Care Trends, Disparities, and Outcomes
Effect of Endothelin Receptor Antagonists (ERAs) on CKD: A Systematic Review and Meta-Analysis